Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.7 0.01  (0.37%)
TradingVolume：2478.48
03-27
2024
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Publisher：
03-14
2024
NOTICE OF BOARD MEETING
Publisher：
03-04
2024
FIRST PATIENT ENROLLED FOR PHASE 3 CLINICAL STUDY OF THE GROUP'S INNOVATIVE FORMULATION LY01610
Publisher：
03-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Publisher：
02-01
2024
UPDATED PROGRESS IN RELATION TO THE MARKETING REVIEW OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) IN THE UNITED STATES
Publisher：
02-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Publisher：
01-12
2024
INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
Publisher：
01-03
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Publisher：
12-06
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
12-06
2023
CHANGE OF NON-EXECUTIVE DIRECTOR
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：2478.48
2.7
0.01  (0.37%)
Announcement & Circular
03-27
2024
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
03-14
2024
NOTICE OF BOARD MEETING
03-04
2024
FIRST PATIENT ENROLLED FOR PHASE 3 CLINICAL STUDY OF THE GROUP'S INNOVATIVE FORMULATION LY01610
03-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
02-01
2024
UPDATED PROGRESS IN RELATION TO THE MARKETING REVIEW OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) IN THE UNITED STATES
02-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
01-12
2024
INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
01-03
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
12-06
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
12-06
2023
CHANGE OF NON-EXECUTIVE DIRECTOR
First
1
2
3
4
5
Last